Bio-equivalence
Bio-equivalence is defined as the observation and finding similarities of one or more drugs. Formulations involve the same active substance or element are called bio-equivalence. If their rate of absorption and formulations are identical, they are pronounced to be bioequivalence drugs. The United States food and Drug Administration (FDA) has explained bio-equivalence as "the absence of a significant difference in the rate and range to which the active ingredient or active subdivision in pharmaceutical equivalents or pharmaceutical substitute becomes available at the site of drug action when administered at the same molar dose below similar conditions in an appropriately designed study.
- Rate Of immersion
- Expression of Medicines
Related Conference of Bio-equivalence
9th International Conference on Global Toxicology and Risk Assessment
Bio-equivalence Conference Speakers
Recommended Sessions
- Behavior toxicology
- Bio-availability
- Bio-equivalence
- Biochemical Pharmacology
- Biologic drugs
- Clinical and medical pharmacology
- Drug discovery and Drug development
- Drug Safety
- Environmental Toxicology
- Genotoxicity
- Microbial Toxicology
- Molecular Pharmacology
- Nanomedicine and Nanotechnology
- Pharmaceutical biotechnology
- Pharmacodynamics
- Pharmacogenomics
- Pharmacokinetics
- Pharmacology and Toxicology
- Pharmacovigilance
- Route of administration
Related Journals
Are you interested in
- Advanced Risk Assessment Methodologies - GLOBAL TOXICOLOGY 2026 (France)
- Chemical Mixtures and Cumulative Risk - GLOBAL TOXICOLOGY 2026 (France)
- Computational Toxicology and AI-Driven Models - GLOBAL TOXICOLOGY 2026 (France)
- Crisis Toxicology and Emergency Response - GLOBAL TOXICOLOGY 2026 (France)
- Ecotoxicology and Wildlife Risk Assessment - GLOBAL TOXICOLOGY 2026 (France)
- Endocrine Disruptors and Hormonal Toxicology - GLOBAL TOXICOLOGY 2026 (France)
- Environmental Toxicants and Ecosystem Health - GLOBAL TOXICOLOGY 2026 (France)
- Food Safety, Contaminants, and Toxicological Evaluation - GLOBAL TOXICOLOGY 2026 (France)
- Forensic and Analytical Toxicology - GLOBAL TOXICOLOGY 2026 (France)
- Genotoxicity and Carcinogenic Risk - GLOBAL TOXICOLOGY 2026 (France)
- Green Toxicology and Sustainable Chemical Design - GLOBAL TOXICOLOGY 2026 (France)
- Human Biomonitoring and Exposure Science - GLOBAL TOXICOLOGY 2026 (France)
- Immunotoxicology and Host Defense - GLOBAL TOXICOLOGY 2026 (France)
- Industrial Toxicology and Workplace Safety - GLOBAL TOXICOLOGY 2026 (France)
- Innovations in Predictive Toxicology - GLOBAL TOXICOLOGY 2026 (France)
- Marine and Aquatic Toxicology - GLOBAL TOXICOLOGY 2026 (France)
- Nanotoxicology and Engineered Nanomaterials - GLOBAL TOXICOLOGY 2026 (France)
- Neurotoxicology and Behavioral Effects - GLOBAL TOXICOLOGY 2026 (France)
- Pharmaceutical and Clinical Toxicology - GLOBAL TOXICOLOGY 2026 (France)
- Public Health Toxicology and Community Risk - GLOBAL TOXICOLOGY 2026 (France)
- Regulatory Toxicology and Global Compliance - GLOBAL TOXICOLOGY 2026 (France)
- Toxicity of Emerging Contaminants - GLOBAL TOXICOLOGY 2026 (France)
- Toxicokinetics and Toxicodynamics - GLOBAL TOXICOLOGY 2026 (France)
- Toxicology in Consumer Products - GLOBAL TOXICOLOGY 2026 (France)
- Toxicology of Air Pollutants and Respiratory Health - GLOBAL TOXICOLOGY 2026 (France)
